CCA
Catalyst Capital Advisors’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.2K | Sell |
360
-89
| -20% | -$6.22K | ﹤0.01% | 428 |
|
|
2025
Q1 | $33K | Hold |
449
| – | – | ﹤0.01% | 393 |
|
|
2024
Q4 | $29.4K | Sell |
449
-35,750
| -99% | -$2.34M | ﹤0.01% | 409 |
|
|
2024
Q3 | $2.82M | Buy |
36,199
+35,641
| +6,387% | +$2.78M | 0.06% | 96 |
|
|
2024
Q2 | $43.5K | Buy |
558
+17
| +3% | +$1.33K | ﹤0.01% | 258 |
|
|
2024
Q1 | $36.7K | Buy |
+541
| New | +$36.7K | ﹤0.01% | 269 |
|
|
2023
Q4 | – | Sell |
-438
| Closed | -$29.7K | – | 377 |
|
|
2023
Q3 | $29.7K | Buy |
438
+106
| +32% | +$7.18K | ﹤0.01% | 278 |
|
|
2023
Q2 | $23.8K | Sell |
332
-15
| -4% | -$1.07K | ﹤0.01% | 301 |
|
|
2023
Q1 | $24.1K | Sell |
347
-130
| -27% | -$9.02K | ﹤0.01% | 287 |
|
|
2022
Q4 | $32.3K | Sell |
477
-73,845
| -99% | -$5.01M | ﹤0.01% | 271 |
|
|
2022
Q3 | $4.08M | Sell |
74,322
-1,834
| -2% | -$101K | 0.15% | 67 |
|
|
2022
Q2 | $5.03M | Buy |
76,156
+75,227
| +8,098% | +$4.97M | 0.21% | 56 |
|
|
2022
Q1 | $62K | Buy |
+929
| New | +$62K | ﹤0.01% | 287 |
|